Rituximab alone as induction therapy for membranous lupus nephritis: A multicenter retrospective study

The optimal treatment for pure membranous lupus nephritis (MLN) remains undetermined. Rituximab constitutes a promising therapeutic option for lupus nephritis and is currently being evaluated for use in idiopathic membranous nephritis. We retrospectively analysed the efficacy and tolerance of rituxi...

Descripción completa

Detalles Bibliográficos
Autores principales: Chavarot, Nathalie, Verhelst, David, Pardon, Agathe, Caudwell, Valérie, Mercadal, Lucile, Sacchi, Antoinette, Leonardi, Catherine, Le Guern, Véronique, Karras, Alexandre, Daugas, Eric
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer Health 2017
Materias:
5200
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5502178/
https://www.ncbi.nlm.nih.gov/pubmed/28682905
http://dx.doi.org/10.1097/MD.0000000000007429

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5502178/
https://www.ncbi.nlm.nih.gov/pubmed/28682905
http://dx.doi.org/10.1097/MD.0000000000007429

Ejemplares similares